Asia Pacific Medical Device Outsourcing Market Size & Outlook
The medical device outsourcing market in Asia Pacific is expected to reach a projected revenue of US$ 180,217.8 million by 2033. A compound annual growth rate of 13.8% is expected of Asia Pacific medical device outsourcing market from 2026 to 2033.
Asia Pacific medical device outsourcing market highlights
The Asia Pacific medical device outsourcing market generated a revenue of USD 65,526.9 million in 2025.
The market is expected to grow at a CAGR of 13.8% from 2026 to 2033.
In terms of segment, cardiology was the largest revenue generating application in 2025.
General & Plastic Surgery is the most lucrative application segment registering the fastest growth during the forecast period.
Country-wise, Australia is expected to register the highest CAGR from 2026 to 2033.
Asia Pacific data book summary
Market revenue in 2025
USD 65,526.9 million
Market revenue in 2033
USD 180,217.8 million
Growth rate
13.8% (CAGR from 2026 to 2033)
Largest segment
Cardiology
Fastest growing segment
General & Plastic Surgery
Historical data covered
2021 - 2024
Base year for estimation
2025
Forecast period covered
2026 - 2033
Quantitative units
Revenue in USD million
Market segmentation
Cardiology, Diagnostic imaging, Orthopedic, IVD, Ophthalmic, General & Plastic Surgery, Drug Delivery, Dental, Endoscopy, Diabetes Care, Other Application
Key market players worldwide
SGS AG, Labcorp Holdings Inc, Eurofins Scientific SE, Pace Analytical Services, Intertek Group PLC, Wuxi AppTec Co Ltd, Sotera Health Co Ordinary Shares, Charles River Laboratories International Inc, Medical Device Testing Services, FREYR Battery Inc, PAREXEL, Accell, Genpact Ltd, Criterium Inc., Promedica International, Medpace Holdings Inc, Icon PLC, IQVIA Holdings Inc, Integer Holdings Corp, Tecomet, Jabil Inc, Flex Ltd, Celestica Inc Ordinary Shares (Subordinate Voting), Sanmina Corp, Plexus Corp, Molex, Steris PLC, West Pharmaceutical Services Inc, NAMSA, TUV SUD, RJR Consulting, Mandala International, Global Regulatory Partners, Emergo Group, BioTeknica Engineering & Regulatory Services
Other key industry trends
In terms of revenue, Asia Pacific region accounted for 41.5% of the global medical device outsourcing market in 2025.
Globally, Asia Pacific is projected to lead the regional market in terms of revenue in 2033.
North America is the fastest growing regional market and is projected to reach USD 117,608.0 million by 2033.
Asia Pacific medical device outsourcing market held the largest share 41.3% in 2023 and is expected to witness lucrative growth owing to the availability of several opportunities in this region, especially in Japan, China, and India. Some of the factors such as improved regulatory framework, high-cost savings, a large number of clinical trials conducted in the region and increase in the number of medical device companies venturing into the region are expected to drive the Asia Pacific market.
Furthermore, availability of a skilled workforce within the region at a lower cost compared to the U.S. is another factor that is anticipated to propel the market growth. Furthermore, outsourcing of certain services such as business process outsourcing, knowledge process outsourcing, clinical data management, regulatory writing, pharmacovigilance, and medical coding has witnessed an increase in the past 5 years. These services are majorly outsourced to countries such as the Philippines, India, Korea, Japan, Malaysia, Singapore, and Australia.
Asia Pacific Medical Device Outsourcing Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Medical Device Outsourcing Market Outlook will help companies and investors design strategic landscapes.
Cardiology was the largest segment with a revenue share of 23.45% in 2025.
Horizon Databook has segmented the Asia Pacific medical device outsourcing market based on cardiology, diagnostic imaging, orthopedic, ivd, ophthalmic, general & plastic surgery, drug delivery, dental, endoscopy, diabetes care, other application covering the revenue growth of each sub-segment from 2021 to 2033.
Asia Pacific medical device outsourcing market held the largest share 41.3% in 2023 and is expected to witness lucrative growth owing to the availability of several opportunities in this region, especially in Japan, China, and India. Some of the factors such as improved regulatory framework, high-cost savings, a large number of clinical trials conducted in the region and increase in the number of medical device companies venturing into the region are expected to drive the Asia Pacific market.
Furthermore, availability of a skilled workforce within the region at a lower cost compared to the U.S. is another factor that is anticipated to propel the market growth. Furthermore, outsourcing of certain services such as business process outsourcing, knowledge process outsourcing, clinical data management, regulatory writing, pharmacovigilance, and medical coding has witnessed an increase in the past 5 years. These services are majorly outsourced to countries such as the Philippines, India, Korea, Japan, Malaysia, Singapore, and Australia.
Asia Pacific Medical Device Outsourcing Market Application Outlook (Revenue, USD Million , 2021-2033)
Cardiology
Diagnostic imaging
Orthopedic
IVD
Ophthalmic
General & Plastic Surgery
Drug Delivery
Dental
Endoscopy
Diabetes Care
Other Application
Asia Pacific Medical Device Outsourcing Market Services Outlook (Revenue, USD Million , 2021-2033)
Quality Assurance Services
Regulatory Consulting Services
Product Design & Development Services
Product Testing & Sterilization Services
Product Implementation Services
Product Upgrade Services
Product Maintenance Services
Contract Manufacturing Services
Asia Pacific Medical Device Outsourcing Market Class Type Outlook (Revenue, USD Million , 2021-2033)
Class I
Class II
Class III
Reasons to subscribe to Medical Device Outsourcing Market Outlook databook
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Medical Device Outsourcing Market Outlook databook
Our clientele includes a mix of Medical Device Outsourcing Market Outlook companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific Medical Device Outsourcing Market Outlook, including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific Medical Device Outsourcing Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Asia Pacific Medical Device Outsourcing Market, 2021-2033 (US$M)